Post-Mortem Findings of ADHD Medications in Finland: Trends, Substance Use and Mortality Patterns in Medico- Legal Deaths, 2016–2024
This retrospective study of Finnish medico-legal deaths from 2016 to 2024 reveals that while detections of ADHD medications in post-mortem cases have risen in parallel with prescription rates, fatalities directly attributed to these drugs remain rare, with the deceased predominantly representing a high-risk subgroup characterized by significant substance-use comorbidity and unnatural causes of death.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, many people die in ways that are not caused by natural illness. In Finland, researchers investigated a specific group of these cases to understand the role of attention deficit hyperactivity disorder, or ADHD. This is a common brain condition that makes it difficult to focus, sit still, or control impulses. Because of these challenges, people with ADHD are at a higher risk for accidents, substance use, and suicide. To help manage these symptoms, doctors often prescribe stimulant medications, which act like a gentle nudge to the brain's attention systems. While these drugs are meant to save lives by reducing risky behavior, they are powerful substances that can also be dangerous if misused or taken in large amounts. The question facing scientists and doctors is whether the rise in these prescriptions is leading to more deaths, or if the people who die are a specific group struggling with other severe problems.
In Finland, researchers decided to look directly at the bodies of people who had died unexpectedly to see what was actually in their systems. Between 2016 and 2024, they examined every single case where a medical examiner found either methylphenidate or amphetamine in the body. Methylphenidate is a common prescription drug for ADHD, while amphetamine is a broader category that includes both prescription ADHD medications and illegal street drugs. The team, led by experts from the University of Helsinki and the Finnish Institute for Health and Welfare, did not just count the drugs; they looked at the entire picture of the person's life and death. They checked for alcohol, other drugs, the official cause of death, and whether the person had a known history of ADHD or was taking medication for it. Their goal was to understand who these people were, how they died, and what role the medications played in their final moments.
The results revealed a story of two very different groups. First, the number of people found with methylphenidate in their bodies grew steadily every year, matching the rise in prescriptions across the country. However, despite this increase, very few of these deaths were actually caused by the drug itself. Only about two and a half percent of the people who had methylphenidate in their system died from a poisoning by that specific drug. Most of the time, the drug was present, but it was not the reason they died. Instead, these individuals often had other serious issues, such as using multiple drugs or struggling with alcohol.
In contrast, the story for amphetamine was different. The number of people with amphetamine in their systems rose sharply until 2020 and then leveled off. But unlike methylphenidate, amphetamine was directly responsible for death in nearly one out of every five cases where it was found. This suggests that when amphetamine appears in a death investigation, it is much more likely to be the cause of the tragedy. The researchers noted that many of these cases involved illegal amphetamine use, often mixed with other substances, rather than just the prescribed medication.
A striking pattern emerged when the researchers looked at the lives of the people who died. In the vast majority of cases, the deceased had used other substances besides the ADHD medication. For those with methylphenidate, about three out of four had used other drugs like benzodiazepines, opioids, or cannabis. For those with amphetamine where an ADHD diagnosis was documented, nearly all had used other substances. Alcohol was also a major factor, appearing in about one out of every four cases. The most common way these people died was by accident, such as a car crash or an overdose, rather than by suicide or natural causes. While suicide was a significant factor, accounting for about one out of every five deaths, the sheer number of accidental deaths pointed to a life lived on the edge, where impulse and risk-taking led to fatal outcomes.
The study also highlighted a gap in how we track these tragedies. In many cases, the medical records did not clearly state whether the person had a diagnosis of ADHD or was taking medication for it. The researchers found that as time went on, more of these details were being recorded, but for a large portion of the cases, this information was missing. This makes it hard to know exactly how many of the people who died were actually patients being treated for ADHD versus those using the drugs illegally. The few cases where the researchers could confirm the person was taking prescribed medication showed that even in these treated individuals, the presence of other drugs was almost universal.
Ultimately, the findings paint a clear picture of a high-risk group. The people who died with ADHD medications in their systems were not the average patient taking a pill to help them focus at work or school. They were individuals who were already struggling with severe substance use, mental health challenges, and a pattern of risky behavior. The medications were often just one part of a much larger, more dangerous mix. While the rise in methylphenidate prescriptions has not led to a wave of poisonings, the presence of amphetamine in death investigations remains a serious warning sign. The study suggests that to prevent these early deaths, the focus must be on helping the most vulnerable people who are already using multiple substances, rather than simply worrying about the medications themselves. By understanding that these deaths are usually the result of a complex web of factors, doctors and families can better target their efforts to save lives.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.